These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7529098)

  • 1. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
    Maisonneuve P; Noël L
    Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analytical study of the Abbott and Ortho tests for screening and confirmation of anti-HCV antibodies. Le groupe de Travail "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Janot C; Couroucé AM; Boudart D; Cotte C; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M; Mattlinger B
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):171-82. PubMed ID: 1384522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C virus and transfusion: policy regarding the donation and the donor. Groupe "Hépatites Virales" de la Société Nationale de Transfusion Sanguine].
    Moncharmont P; Janot C; Boudart D; Cotte C; Couroucé AM; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):205-10. PubMed ID: 1329793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serological diagnosis of anti-HCV antibodies. Tests for screening and confirmation: analytical study. Le groupe "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):163-9. PubMed ID: 1329791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.
    Mazda T; Nakata K; Bannai M; Miyamura T; Chiba J; Ohba H; Kaminuma Y; Katayama T
    Transfus Med; 1993 Jun; 3(2):149-51. PubMed ID: 7690640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative results in detection of HCV antibodies by using a rapid HCV test, ELISA and immunoblot.
    Poovorawan Y; Theamboonlers A; Chumdermpadetsuk S; Thong CP
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):647-9. PubMed ID: 7545315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus blood donor screening: recombinant immunoblot assay interpretation re-examined.
    Perrons CJ; Garson JA
    Vox Sang; 1993; 64(4):253. PubMed ID: 7685973
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 12. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 13. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
    Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
    Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV and blood transfusion.
    Reesink HW; van der Poel CL; Cuypers HT; Lelie PN
    Arch Virol Suppl; 1992; 4():241-3. PubMed ID: 1280507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of anti-HCV antibodies in France. Viral Hepatitis Study Group of the French Blood Transfusion Society.
    Aguelles O; Janot C
    Arch Virol Suppl; 1992; 4():249-52. PubMed ID: 1450696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-A, non-B hepatitis and the anti-HCV assay.
    Barbara JA; Contreras M
    Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening tests for anti-HCV antibodies: comparative results].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):183-91. PubMed ID: 1384523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ELISA kits for detection of anti-HCV antibodies. "Viral Hepatitis" Working Group of the French Society of Blood Transfusion].
    Janot C
    Transfus Clin Biol; 1994; 1(1):47-8. PubMed ID: 7514475
    [No Abstract]   [Full Text] [Related]  

  • 20. [The serodiagnosis of viral hepatitis C].
    Golosova TV; Somova AV
    Klin Lab Diagn; 1995; (2):19-21. PubMed ID: 7620768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.